Drug developer ChemoCentryx has price...

Drug developer ChemoCentryx has priced its IPO in a range of...

There are 1 comment on the Seeking Alpha story from Jan 23, 2012, titled Drug developer ChemoCentryx has priced its IPO in a range of.... In it, Seeking Alpha reports that:

Drug developer ChemoCentryx has priced its IPO in a range of $14-$16, and says it plans to sell 4M shares under the ticker CCXI.

Join the discussion below, or Read more at Seeking Alpha.

Joan

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

ChemoCentryx Discussions

Title Updated Last By Comments
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News GSK licenses experimental arthritis treatment f... (May '12) May '12 Robson 1
News GSK Licenses RA Drug from ChemoCentryx (May '12) May '12 Robson 1
News GSK Exercises Option to License ChemoCentryx's ... (May '12) May '12 Robson 1
News GlaxoSmithKline Exercises Option to License Che... (May '12) May '12 Joan 1
News GSK obtains exclusive license to ChemoCentryx's... (May '12) May '12 Joan 1
News Market Report, "Diabetic Nephropathy - Pipeline... (May '12) May '12 Joan 1
More from around the web